Medicine Routes
Map Regional E-Prescriptions, Cross-Region Supply, Private and EU Prescriptions, On-Call Pharmacies, Controlled Medicines, and Imports
The prescriber, funding route, medicine category, location, and travel purpose determine how dispensing works.
Choose by prescriber and funding
A clinician in an autonomous-community public health service normally creates a regional electronic prescription linked to the individual health card. Through the SNS interoperability system, an active medicine can generally be dispensed in another participating autonomous community by presenting that card. The system shows authorised items and contribution status, not every clinical note.
A private clinician uses a compliant private electronic or paper prescription. The patient normally pays the medicine's full retail price even when privately insured, unless the policy separately reimburses it. A private prescription does not enter the public repeat plan automatically. A public clinician must make an independent clinical decision rather than copy it merely for subsidy.
A prescription from another EU or EEA state can be recognised when it contains the required patient, prescriber and medicine information and the product is authorised and available in Spain. Brand, strength or formulation differences can prevent exact supply. Cross-border dispensing is separate from EHIC: the patient often pays upfront and requests reimbursement from the competent institution. A prescription from outside the recognised framework may require a Spanish prescriber.
Know the specialist routes
A farmacia de guardia is an on-call pharmacy designated under regional or local arrangements. Use the official pharmacy-college or authority listing and verify the time and address. It dispenses under ordinary legal rules; being open at night does not convert a prescription-only medicine into an over-the-counter product. Urgent symptoms still need clinical care or 112.
A pharmacist can supply a lawful equivalent or substitute only within applicable medicine rules and must protect dose, active ingredient, form and clinical restrictions. Some products cannot be substituted casually. Ask the pharmacist to explain any change and check appearance before taking it.
Narcotic, psychotropic, certain stimulant, opioid, sedative, hormone, injectable or specialist medicines can require special prescriptions, identity, shorter windows, hospital dispensing or prior authorisation. International carriage can require a medical letter, Schengen certificate, export or destination permission. Start with the prescriber, AEMPS, consulate and destination authority well before travel.
Exceptional import of a medicine unavailable or unauthorised in Spain is an official clinician and AEMPS pathway, not personal online shopping. The lawful recommendation is public e-prescription for eligible public care, private prescription for private treatment, recognised EU prescription for an eligible temporary cross-border case, on-call pharmacy only for lawful urgent dispensing, and prescriber-led review for controlled, unavailable or imported treatment.
Eligibility
Verify the Prescriber, Health Card, Coverage Group, Authorisation, Cross-Border Connection, Medicine, and Identity
A clinically appropriate prescription must also satisfy legal, technical, funding, and identity conditions.
Establish clinical and public eligibility
A doctor, dentist, podiatrist or other legally authorised professional can prescribe within professional scope. The prescriber must assess indication, contraindications, interactions, dose, duration and monitoring. A pharmacist can advise and dispense but cannot create a new prescription-only treatment merely because the patient has an old box or foreign medicine list.
Public electronic dispensing requires active SNS entitlement and the individual health card recognised by the connected system. A paper token or printed medication plan can help explain treatment but may not replace the card. A patient whose regional card is pending should ask the health service for provisional dispensing instructions rather than borrow another person's card.
Funding depends on whether the medicine and presentation are included, the prescription is issued through the qualifying public route, any diagnostic or specialist approval is complete, and the person's current contribution category is correct. The same active ingredient can have funded and non-funded presentations. A private prescription or non-funded indication can require full price.
Some medicines require prior validation, specialist initiation, hospital pharmacy, laboratory monitoring or defined diagnosis. An expired authorisation cannot be solved by paying a normal pharmacy copayment. Contact the prescribing team before supply ends and preserve the renewal request.
Test cross-border and personal conditions
A recognised EU prescription needs sufficient patient identity, issue date, prescriber identity, professional qualification, direct contact, signature where applicable, active ingredient, strength, form, quantity and dosage. The Spanish pharmacist must still apply domestic dispensing and safety law. Controlled substances can be excluded from ordinary cross-border recognition.
Citizenship, worker, student, family or self-employed status mainly affects the healthcare entitlement and reimbursement institution rather than the pharmacology. A temporary visitor using an EU prescription may pay upfront. A resident should not keep using a visitor workaround when a Spanish prescriber must monitor chronic treatment.
Identity can be requested for controlled medicines, cross-border prescriptions, reimbursement or to resolve a name mismatch. Show the document; do not surrender the only passport. A parent, carer or authorised person can collect many medicines with the correct health card or prescription, but special products can require patient identity or stricter handling.
Age, pregnancy, kidney or liver function, allergy, driving, occupation, sport antidoping rules and other medicines can change safety even when the prescription is technically valid. Tell the prescriber and pharmacist about changes. The pharmacy decides lawful dispensing, the prescriber decides treatment, the regional service decides public authorisation and contribution data, AEMPS controls medicine status, and the foreign institution decides reimbursement.
Medicine Records
Prepare the Health Card, Prescription, Identity, Medication Plan, Contribution Status, Authorisation, and Invoice File
Accurate product and patient identifiers prevent dose errors, duplicate treatment, and failed reimbursement.
Build the clinical and dispensing file
For each medicine record the active ingredient, brand if relevant, strength, pharmaceutical form, dose, timing, route, indication, start, planned end, prescriber, monitoring and known reaction. Add allergies, pregnancy, kidney or liver condition, anticoagulants and other high-risk interactions. Photograph the Spanish box and batch only as backup; do not use a photo as dosing authority after treatment changes.
Keep the current regional health card, medication plan, electronic prescription status or token, private or paper original, authorisation, specialist report and renewal date. For an EU prescription, preserve the original or compliant electronic record and prescriber contact. A pharmacy can retain a paper prescription when the dispensing law requires it; ask for an endorsed copy or receipt where needed for reimbursement.
Controlled travel requires the prescription, medical letter using active ingredient, quantity and journey dates, and any Schengen or destination certificate. Check whether an original, translation or legalisation is required by the destination. Spanish routine prescriptions generally do not require legalisation for domestic use.
Preserve price and safety evidence
Save the pharmacy ticket or invoice showing legal pharmacy, date, medicine presentation, quantity, full price, patient contribution and amount paid. For cross-border reimbursement, add prescription, identity, EHIC or entitlement evidence, travel dates and the foreign institution's claim form. A simple card receipt without medicine details is weak evidence.
If the contribution category is wrong, retain the receipt, active or pension status and correction request. If a medicine is unavailable, record the exact national code or presentation, pharmacy check, CIMA status, alternative proposed and prescriber response. A shortage of one pack size does not prove every strength or therapeutic alternative is unavailable.
For suspected adverse reaction, keep onset, symptoms, dose, administration time, co-medications, food, test results, clinical treatment, batch and outcome. The AEMPS citizen report asks for the reaction, suspected medicine and patient and provides a reference. Preserve it, but do not send full medical records through an unverified link.
Reconcile legal name, birth date, health number, contribution category, prescription name, medicine, dose and dates. Correct duplicate patient profiles or expired card status with the regional service. Never surrender the only identity document or allow an online seller to retain passport data without a lawful need.
Keep a current one-page list for every clinician and pharmacist and archive discontinued medicines separately with the stop reason. Return unused or expired household medicines and packaging through the pharmacy's authorised collection route rather than sharing, selling or flushing them.
Use the Pharmacy
Obtain the Prescription, Present the Card, Check Equivalents and Stock, Pay, Record, Plan Travel, and Report Reactions
A safe dispensing conversation verifies patient, product, instructions, price, availability, and the next refill.
Complete each dispensing safely
- Obtain a current clinical assessment. Tell the prescriber every medicine, supplement, allergy, reaction, pregnancy, organ condition and treatment goal. Ask for active ingredient, dose, duration, monitoring and what to do after a missed dose.
- Confirm the prescription route. Check whether it is public electronic, private electronic, paper, EU cross-border, special controlled or hospital pharmacy. Verify authorisation and renewal before leaving the clinic.
- Present the correct evidence. Use the individual health card for interoperable public dispensing, or the original private or EU prescription and identity where required. EHIC is not the domestic pharmacy card.
- Ask about the exact product. Confirm active ingredient, strength, form, pack size, availability, storage and expiry. If the brand or appearance changes, ask the pharmacist to explain lawful substitution before taking it.
- Check interactions and use. Ask about food, alcohol, driving, sun, other medicines, devices, measuring technique, refrigeration and warning symptoms. Obtain written or accessible instructions where possible.
- Pay and retain proof. Check the contribution or full price and keep the itemised receipt. If the contribution category is wrong, preserve it for correction rather than arguing only from memory.
- Plan the next supply. Note when the next pack becomes available, clinical review, test and authorisation expiry. Request chronic renewal early without accumulating beyond clinical and legal limits.
- Handle shortage through professionals. Ask the pharmacy to check the exact presentation and the prescriber to select an authorised alternative when needed. The live AEMPS shortage page distinguishes pharmacy-manageable problems from prescriber or hospital action. Do not alter dose or buy from strangers.
- Plan travel. Calculate lawful quantity, keep medicine in original labelled packaging, carry the prescription and medical letter, maintain temperature, divide only where safe and verify controlled-drug and destination rules.
- Respond to suspected harm. Seek urgent care or call 112 for severe allergy, breathing difficulty, collapse, seizure, major overdose or dangerous reaction. Contact the prescriber or pharmacist for non-emergency review and submit a pharmacovigilance report afterward where appropriate.
A representative can collect ordinary medicines under the applicable identification rules, but cannot replace a required clinical review. Online portals can renew or display plans only where the region provides it. After any change, update the shared medication list, carers, primary clinician and relevant specialist so conflicting prescriptions do not continue.
Costs
Calculate 2026 Public Contributions, Full Private Price, Non-Funded Products, Night Access, Delivery, EU Reimbursement, and Alternatives
The same medicine can cost differently by prescriber route, funding status, income category, presentation, and country.
Apply the current public contribution
As checked on 26 August 2026, the May 2026 law sets community-pharmacy contributions by status and income. Active users generally pay 40 percent below EUR 18,000, 45 percent from EUR 18,000 to below EUR 60,000, 50 percent from EUR 60,000 to below EUR 100,000, and 60 percent from EUR 100,000. Most pensioners pay 10 percent, while the EUR 100,000 band pays 60 percent. Exempt groups and special reduced-contribution products follow their current rules.
The reform introduced monthly maximums of EUR 8.23 for active users below EUR 9,000 and foreign nationals under the no-legal-residence public route, EUR 18.52 from EUR 9,000 to below EUR 18,000, and EUR 61.75 from EUR 18,000 to below EUR 35,000. Reduced-contribution products have their own current cap. These amounts can change, and regional systems can implement caps or refunds operationally, so keep receipts and verify the live process.
Public funding also depends on the medicine, presentation, indication, prescriber and authorisation. A non-funded medicine, private prescription or product outside the qualifying route usually costs the full regulated retail amount. Private insurance commonly excludes outpatient medicines unless its terms provide reimbursement. The convenio especial leaves outpatient pharmaceuticals at 100 percent patient cost.
Include every pharmacy and cross-border cost
A lawful equivalent can reduce public or private cost where substitution rules permit, but do not choose solely by pack price when strength, form or device differs. Ask for the exact active ingredient and dose. Non-medicine products, supplements, cosmetics, dressings, devices and delivery can be freely or differently priced and may not be funded.
On-call pharmacy access does not create a universal national night surcharge; regional rules and services vary. Ask for an itemised receipt rather than assuming a higher total is an emergency fee. Home delivery must follow pharmacy law and can have a separate service cost. Online sale is legal only for non-prescription medicines through registered pharmacy sites.
An EU cross-border prescription can require full upfront payment in Spain. Reimbursement depends on the responsible institution's rules and can be limited to its tariff. Preserve the prescription and itemised invoice. Currency and transfer cost can apply to a later foreign claim.
Add prescriber consultation, tests, authorisation, travel to an available pharmacy, refrigeration, controlled-drug certificate, translation, replacement of lost medicine and unused packs after a treatment change. Avoid counterfeit bargains and paid intermediaries.
If the pharmacy price or contribution appears wrong, first verify the exact national product code, pack, prescription route and contribution status. Request a corrected invoice or regional category review. Returning a dispensed medicine is restricted for safety, so do not expect an ordinary retail refund after leaving merely because another pharmacy quotes less.
Timing and Changes
Manage Validity, Dispensing Windows, Repeat Schedules, Regional Moves, Shortages, Travel Supply, and Reimbursement
Medicine continuity depends on clinical review and lawful availability, not merely the expiry date printed on a box.
Track medicine-specific clocks
Prescription validity and dispensing windows depend on electronic or paper format, acute or chronic schedule, controlled status, product and regional system. Do not apply one remembered deadline to every medicine. Check the active plan, next available date, packs authorised, end date, clinical review, laboratory test and prior-authorisation expiry in the patient portal or with the prescriber and pharmacist.
A chronic plan can release packs at intervals to prevent unsafe accumulation. Early travel does not automatically unlock the entire course. Ask the prescriber and pharmacy about a lawful travel supply and insurer or regional exception well before departure. Controlled medicines can have narrower quantity and certificate rules.
Cross-region interoperability allows dispensing of many active public prescriptions using the Spanish health card, but recently issued changes, special products, hospital medicines or technical outages can require the home region or prescriber. Carry the medication plan and contact details without assuming a printed token alone authorises supply.
Plan shortages and life changes
CIMA shortage information updates continuously by exact strength, form and pack. Start monitoring before the last dose, ask the pharmacy about procurement, and contact the prescriber when AEMPS says another treatment must be chosen. Do not ration, double, switch formulation or source an online product independently. Preserve evidence if missed treatment causes clinical risk.
Moving autonomous community requires new regional health-card registration and medication reconciliation. The national interoperability record helps, but the new primary-care team may need to recreate monitoring, specialist authorisation or hospital-pharmacy supply. Bring recent reports and enough lawful medicine for the transition.
Job change, retirement, unemployment, graduation, separation or income-data correction can change the contribution category without changing the prescription. Check the pharmacy receipt and correct the underlying INSS, tax or regional record. A pending correction does not itself alter the amount charged; ask about the refund route and preserve receipts.
Before international travel, confirm destination legality, quantity, original packaging, temperature, documentation and time-zone schedule. Ask the airline about refrigerated or injectable supplies. Do not place all essential medicine in checked baggage. For return, verify whether Spain permits personal carriage and whether an exceptional import is required.
Cross-border reimbursement has its own filing deadline and evidence rules. File the original or accepted copy, invoice, payment, identity and entitlement through the competent institution and retain the submission receipt. A pending claim does not make a foreign pharmacy refund the purchase.
After any new diagnosis, pregnancy, kidney change, hospital discharge or adverse reaction, reconcile the full list immediately. The next milestone is not merely the next refill but a confirmed prescriber, monitoring plan, active prescription, lawful supply, correct contribution and documented response if availability or safety changes.
Problems and Help
Fix EHIC Confusion, Expired or Foreign Prescriptions, Counterfeits, Controlled Imports, Interactions, Shortages, and Reactions
Use the pharmacist, prescriber, regional service, AEMPS, insurer, and emergency system for the distinct part each controls.
Diagnose why dispensing failed
An EHIC proves temporary healthcare coordination but is not the Spanish electronic-prescription card. Present the regional health card or the correct private or cross-border prescription. For an expired prescription, missing required detail, foreign product, controlled medicine, prior-authorisation failure or unavailable presentation, ask the pharmacist to state the specific problem and contact the prescriber. Do not alter or recreate the document yourself.
A foreign brand can use another active ingredient, strength or formulation. Show the original packaging and medical record, but obtain a Spanish clinical review where cross-border recognition does not apply. Never share another person's prescription or card.
Prescription medicines cannot be sold online to the public through Spain's legal distance-sales route. For non-prescription products, use an authorised pharmacy listed by the authority and click the common logo to verify it. The AEMPS online guidance excludes marketplaces and intermediaries. Report suspicious sellers and preserve the URL, payment, package, batch and messages. Do not consume a suspected counterfeit.
Protect treatment and safety
For a shortage, ask the pharmacist to check the exact pack and AEMPS status and the prescriber to select an appropriate alternative. A similar name or dose is not enough. Hospital-only or controlled supply requires the official route. For personal import, follow AEMPS, customs and clinician rules; a courier's guarantee is not permission.
For a possible interaction, dosing error or non-severe reaction, contact the pharmacist and prescriber promptly with the complete list and timeline. Do not stop a medicine with dangerous withdrawal risk without clinical advice. Call 112 for breathing difficulty, facial swelling, collapse, severe skin reaction, seizure, major bleeding, overdose, confusion or another immediate danger. For poisoning advice, the National Institute of Toxicology is 91 562 04 20.
After clinical care, a citizen can report a suspected reaction through the AEMPS NotificaRAM route. Keep the reference. Reporting does not decide malpractice, compensation or product quality and does not replace a prescriber review.
For wrong contribution, dispensing error, privacy or service, complain first to the pharmacy and regional health or pharmacy authority with prescription, receipt, product and chronology. A private-prescription or insurer reimbursement dispute follows provider and insurer complaint routes. Serious injury, counterfeit supply, repeated controlled-drug issue or an expiring reimbursement or legal claim justifies specialist advice.
Bring one indexed file and state the exact remedy: correct prescription, safe alternative, refund, category correction, product investigation, record amendment, insurer payment or legal review. That is faster and safer than visiting multiple pharmacies with the same unresolved defect.